Home › Funds › BIOS Capital Management, LP › ACTU
BIOS Capital Management, LP position in ACTU
ACTUATE THERAPEUTICS INC · Health Care
BIOS Capital Management, LP reported holding 10,049,996 shares of ACTU (ACTUATE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.84B, representing 22.94% of its reported portfolio and ranking #2 among its reported holdings. BIOS Capital Management, LP has disclosed ACTU holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How BIOS Capital Management, LP's ACTU position evolved
BIOS Capital Management, LP first disclosed a stake in ACTU in Q4 2024 at 9,893,651 shares (US$78.8M). The position peaked in Q3 2026 at 10,049,996 shares, worth US$7.84B. Across 8 filings, BIOS Capital Management, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 10,049,996 shares valued at US$7.84B.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 9.89M | $78.75M | New |
| Q1 2025 | 9.89M | $66.98M | Hold |
| Q2 2025 | 9.97M | $60.89M | Add |
| Q3 2025 | 10.05M | $67.23M | Add |
| Q4 2025 | 10.05M | $61.51M | Hold |
| Q1 2026 | 10.05M | $27.54M | Hold |
| Q2 2026 | 10.05M | $15.38M | Hold |
| Q3 2026 | 10.05M | $7.84B | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACTU and 13F data
ACTU (ACTUATE THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ACTU — the largest reported positions include Voss Capital, LP (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on BIOS Capital Management, LP
FAQ
How long has BIOS Capital Management, LP held ACTU?
BIOS Capital Management, LP has disclosed ACTU holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is BIOS Capital Management, LP's current position in ACTU?
As of Q3 2026, BIOS Capital Management, LP holds 10.05M shares of ACTU (ACTUATE THERAPEUTICS INC), valued at $7.84B, representing 22.94% of its reported portfolio and ranking #2.
Has BIOS Capital Management, LP been buying or selling ACTU?
In the latest 13F filing (Q3 2026), BIOS Capital Management, LP held unchanged its position in ACTU. The position peaked in Q3 2026 at 10.05M shares.
Which other funds hold ACTU?
Other major institutional holders of ACTU include Voss Capital, LP, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.